Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin

Open access
Jansen, Patrick A. M., Rodijk-Olthuis, Diana, Hollox, Edward J., Kamsteeg, Marijke, Tjabringa, Geuranne S., de Jongh, Gys J., van Vlijmen-Willems, Ivonne M. J. J., Bergboer, Judith G. M., van Rossum, Michelle M., de Jong, Elke M. G. J., den Heijer, Martin, Evers, Andrea W. M., Bergers, Mieke, Armour, John A. L., Zeeuwen, Patrick L. J. M., Schalkwijk, Joost · 2009 · PLoS ONE

Abstract

BACKGROUND: Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis. METHODOLOGY/PRINCIPAL FINDINGS: We found that systemic levels of hBD-2 showed a weak but significant correlation with beta defensin copy number in healthy controls but not in psoriasis patients with active disease. In psoriasis patients but not in atopic dermatitis patients, we found high systemic hBD-2 levels that strongly correlated with disease activity as assessed by the PASI score. Our findings suggest that systemic levels in psoriasis are largely determined by secretion from involved skin and not by genomic copy number. Modelling of the in vivo epidermal hBD-2 concentration based on the secretion rate in a reconstructed skin model for psoriatic epidermis provides evidence that epidermal hBD-2 levels in vivo are probably well above the concentrations required for in vitro antimicrobial and chemokine-like effects. CONCLUSIONS/SIGNIFICANCE: Serum hBD-2 appears to be a useful surrogate marker for disease activity in psoriasis. The discrepancy between hBD-2 levels in psoriasis and atopic dermatitis could explain the well known differences in infection rate between these two diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0004725

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 177

Metadata

Authors
Jansen, P. A. M., Rodijk-Olthuis, D., Hollox, E. J., Kamsteeg, M., Tjabringa, G. S., de Jongh, G. J., van Vlijmen-Willems, I. M. J. J., Bergboer, J. G. M., van Rossum, M. M., de Jong, E. M. G. J., den Heijer, M., Evers, A. W. M., Bergers, M., Armour, J. A. L., Zeeuwen, P. L. J. M., & Schalkwijk, J.
Venue
PLoS ONE
Published
2009-03-06
Volume
4
Issue
3
Pages
e4725
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2117858129
Cited by
177
References
7
FWCI
5.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin. https://app.cochat.ai/papers/10.1371/journal.pone.0004725
The paper
Jansen, P. A. M., Rodijk-Olthuis, D., Hollox, E. J., Kamsteeg, M., Tjabringa, G. S., de Jongh, G. J., van Vlijmen-Willems, I. M. J. J., Bergboer, J. G. M., van Rossum, M. M., de Jong, E. M. G. J., den Heijer, M., Evers, A. W. M., Bergers, M., Armour, J. A. L., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2009). β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin. PLoS ONE. https://doi.org/10.1371/journal.pone.0004725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.